NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 16 04:00PM ET
10.40
Dollar change
+0.75
Percentage change
7.77
%
IndexRUT P/E15.70 EPS (ttm)0.66 Insider Own4.06% Shs Outstand23.58M Perf Week9.01%
Market Cap241.78M Forward P/E13.00 EPS next Y0.80 Insider Trans-6.52% Shs Float22.31M Perf Month-22.10%
Income16.20M PEG0.54 EPS next Q0.11 Inst Own99.44% Short Float9.72% Perf Quarter-39.99%
Sales293.16M P/S0.82 EPS this Y-20.71% Inst Trans-5.02% Short Ratio6.75 Perf Half Y-33.97%
Book/sh8.72 P/B1.19 EPS next Y44.14% ROA5.86% Short Interest2.17M Perf Year-23.70%
Cash/sh3.60 P/C2.89 EPS next 5Y28.92% ROE8.12% 52W Range8.61 - 21.10 Perf YTD-39.29%
Dividend Est.- P/FCF6.39 EPS past 5Y4.69% ROI6.66% 52W High-50.71% Beta0.94
Dividend TTM- Quick Ratio3.99 Sales past 5Y9.30% Gross Margin73.70% 52W Low20.79% ATR (14)0.69
Dividend Ex-Date- Current Ratio4.52 EPS Y/Y TTM-43.83% Oper. Margin7.03% RSI (14)35.23 Volatility5.13% 4.23%
Employees1037 Debt/Eq0.21 Sales Y/Y TTM5.96% Profit Margin5.52% Recom2.60 Target Price13.00
Option/ShortYes / Yes LT Debt/Eq0.18 EPS Q/Q-34.41% Payout0.00% Rel Volume1.84 Prev Close9.65
Sales Surprise-3.49% EPS Surprise-62.50% Sales Q/Q0.29% EarningsMay 05 AMC Avg Volume321.08K Price10.40
SMA20-14.27% SMA50-19.51% SMA200-29.77% Trades Volume582,686 Change7.77%
Date Action Analyst Rating Change Price Target Change
May-06-25Downgrade Piper Sandler Overweight → Neutral $14
Feb-19-25Downgrade B. Riley Securities Buy → Neutral $23 → $18
Nov-05-24Downgrade Oppenheimer Outperform → Perform
Nov-05-24Downgrade BTIG Research Buy → Neutral
Sep-26-24Initiated B. Riley Securities Buy $23
Nov-13-20Upgrade Oppenheimer Perform → Outperform $55
Oct-22-19Initiated Oppenheimer Perform
Aug-07-19Upgrade BTIG Research Neutral → Buy $62
Jun-13-19Initiated Dougherty & Company Buy $80
Jan-02-19Upgrade Northland Capital Under Perform → Market Perform
May-06-25 12:09PM
03:08AM
May-05-25 05:30PM
04:27PM
04:05PM
09:33AM Loading…
May-02-25 09:33AM
Apr-30-25 05:50PM
Apr-21-25 04:05PM
Apr-07-25 12:58PM
Mar-05-25 04:05PM
Feb-19-25 11:23AM
02:06AM
Feb-18-25 07:20PM
06:17PM
04:05PM
02:52AM Loading…
02:52AM
Feb-05-25 04:05PM
Feb-04-25 08:00AM
Jan-13-25 08:00AM
Jan-01-25 09:40AM
Dec-16-24 03:34PM
Nov-28-24 09:40AM
Nov-26-24 09:15AM
Nov-19-24 04:05PM
Nov-18-24 07:09AM
Nov-12-24 09:40AM
Nov-07-24 09:55AM
Nov-04-24 05:30PM
04:30PM
04:05PM
09:07AM Loading…
Nov-01-24 09:07AM
Oct-28-24 10:01AM
Oct-21-24 04:05PM
Oct-04-24 06:05AM
Oct-02-24 08:00AM
Sep-25-24 12:02PM
08:00AM
Sep-20-24 08:38AM
Sep-16-24 08:00AM
Aug-07-24 09:55AM
09:40AM
09:35AM
09:30AM
Aug-06-24 01:59PM
Aug-05-24 06:15PM
05:11PM
04:05PM
Jul-22-24 04:05PM
Jun-27-24 02:03PM
May-21-24 04:05PM
May-08-24 09:40AM
May-07-24 10:48AM
07:04AM
03:13AM
May-06-24 05:50PM
05:47PM
04:47PM
04:05PM
May-02-24 05:45PM
09:00AM
Apr-26-24 05:45PM
Apr-24-24 07:09AM
Apr-23-24 04:05PM
09:30AM
Apr-18-24 05:45PM
Apr-17-24 09:40AM
09:00AM
Apr-15-24 04:05PM
Apr-12-24 05:45PM
01:53PM
Apr-03-24 12:00PM
Apr-01-24 09:40AM
Mar-14-24 09:40AM
Mar-13-24 09:55AM
Feb-27-24 09:40AM
Feb-26-24 09:55AM
Feb-23-24 09:55AM
Feb-21-24 09:26AM
Feb-20-24 10:39PM
06:34PM
08:40AM
08:11AM
07:38AM
07:30AM
Feb-05-24 04:05PM
Feb-01-24 06:51PM
Jan-29-24 07:30AM
Nov-08-23 07:30AM
Nov-07-23 10:38AM
10:08AM
Nov-06-23 05:44PM
05:03PM
04:05PM
Nov-03-23 08:46AM
Oct-03-23 07:30AM
Oct-02-23 04:05AM
Sep-25-23 08:38AM
Sep-19-23 09:00AM
Sep-07-23 07:30AM
Aug-31-23 04:05PM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Birkemeyer Elaine M.Chief Financial OfficerMay 12 '25Sale9.942,92129,03799,111May 14 05:26 PM
Birkemeyer Elaine M.OfficerMay 12 '25Proposed Sale9.942,92129,037May 12 05:25 PM
Dodd Sheri LouiseChief Executive OfficerMay 08 '25Sale9.833,14930,955181,241May 12 04:34 PM
BURKE WILLIAM WDirectorMay 08 '25Sale9.673,30031,91148,520May 09 04:28 PM
Dodd Sheri LouiseDirectorMay 08 '25Proposed Sale9.833,14930,955May 08 07:17 PM
BURKE WILLIAM WDirectorMay 08 '25Proposed Sale9.673,30031,911May 08 04:46 PM
Ferstler Sherri LeeOfficerApr 03 '25Proposed Sale13.142,35530,945Apr 03 05:30 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 25 '25Sale14.512,06629,980102,032Feb 27 04:29 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 25 '25Sale14.406,46893,16077,540Feb 27 04:28 PM
REUVERS DANIEL L.DirectorFeb 25 '25Sale14.1828,338401,850214,604Feb 27 04:27 PM
REUVERS DANIEL L.OfficerFeb 25 '25Proposed Sale14.1828,338401,851Feb 25 07:35 PM
Burns KristieOfficerFeb 25 '25Proposed Sale14.406,46893,160Feb 25 07:15 PM
Birkemeyer Elaine M.OfficerFeb 25 '25Proposed Sale14.512,06629,980Feb 25 06:54 PM
REUVERS DANIEL L.DirectorFeb 24 '25Sale14.5510,938159,147242,942Feb 24 06:24 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 24 '25Sale14.654,83070,75384,008Feb 24 06:23 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 24 '25Sale14.703,77855,538104,098Feb 24 06:22 PM
REUVERS DANIEL L.OfficerFeb 24 '25Proposed Sale14.5510,938159,147Feb 24 05:23 PM
Burns KristieOfficerFeb 24 '25Proposed Sale14.654,83070,753Feb 24 05:12 PM
Ferstler Sherri LeeOfficerFeb 24 '25Proposed Sale14.792,20932,660Feb 24 04:58 PM
Birkemeyer Elaine M.OfficerFeb 24 '25Proposed Sale14.703,77855,538Feb 24 04:55 PM
Ferstler Sherri LeeSenior VP, SalesAug 12 '24Sale13.071,55020,26338,764Aug 14 04:26 PM
Ferstler Sherri LeeOfficerAug 12 '24Proposed Sale13.071,55020,262Aug 12 05:04 PM